The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...
The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...
960 The Ref on MSN16h
FDA approves Ozempic to reduce risk of kidney disease progression, cardiovascular deathThe Food and Drug Administration approved Ozempic to be used to lessen the risk of kidney disease from getting worse, ...
Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate. Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial (ClinicalTrials.gov Identifier: ...
The FDA has approved 2 additional vial sizes of Niktimvo™ (axatilimab-csfr), 9mg/0.18mL and 22mg/0.44mL, in addition to the 50mg/mL size.
The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic ...
GlobalData on MSN20h
Novo Nordisk secures FDA approval for Ozempic in diabetes with CKDThe US Food and Drug Administration (FDA) has approved Novo Nordisk’s Ozempic (semaglutide) to reduce certain risks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback